Aviva plc (LON:AV - Get Free Report)'s stock price was up 2.6% on Wednesday . The stock traded as high as GBX 608 ($8.22) and last traded at GBX 607.40 ($8.21). Approximately 12,021,676 shares changed hands during trading, The stock had previously closed at GBX 591.80 ($8.00).
Wall Street Analysts Forecast Growth
Separately, JPMorgan Chase & Co. lifted their price target on Aviva from GBX 615 ($8.31) to GBX 635 ($8.58) and gave the stock an "overweight" rating in a report on Thursday, March 6th.
Read Our Latest Stock Analysis on Aviva
Aviva Stock Performance
The firm has a market capitalization of £16.41 billion, a price-to-earnings ratio of 12.59, a PEG ratio of 2.01 and a beta of 0.89. The company has a debt-to-equity ratio of 68.87, a quick ratio of 1.57 and a current ratio of 2.93. The company has a fifty day moving average of GBX 553.78 and a two-hundred day moving average of GBX 515.65.
Aviva (LON:AV - Get Free Report) last announced its quarterly earnings data on Thursday, February 27th. The company reported GBX 23.60 ($0.32) earnings per share for the quarter. Aviva had a return on equity of 14.82% and a net margin of 3.52%. As a group, equities research analysts predict that Aviva plc will post 46.4942529 earnings per share for the current fiscal year.
Aviva Increases Dividend
The business also recently disclosed a dividend, which will be paid on Friday, June 20th. Shareholders of record on Thursday, April 24th will be issued a GBX 23.80 ($0.32) dividend. The ex-dividend date is Thursday, April 24th. This is a boost from Aviva's previous dividend of $11.90. This represents a yield of 4.25%. Aviva's payout ratio is currently 70.07%.
Insider Buying and Selling at Aviva
In other news, insider Amanda Blanc sold 523,728 shares of the business's stock in a transaction on Friday, March 21st. The stock was sold at an average price of GBX 555 ($7.50), for a total transaction of £2,906,690.40 ($3,927,960.00). Insiders own 0.17% of the company's stock.
Aviva Company Profile
(
Get Free Report)
Aviva plc provides various insurance, retirement, investment, and savings products in the United Kingdom, Ireland, Canada, and internationally. The company offers life insurance, long-term health and accident insurance, savings, pension, and annuity products, as well as pension fund business and lifetime mortgage products.
Further Reading
Before you consider Aviva, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aviva wasn't on the list.
While Aviva currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
